Researchers led by Dr. Alex Lehrer at the University of Hawaii (UH) medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and now monkeys from the infection.
Dr. Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
Demonstrating the effectiveness of the vaccine candidate in monkeys (non-human primates) is an important milestone because it typically predicts the vaccine will work in humans, enabling further clinical development.
A strong global initiative to battle Zika has produced more than 30 vaccine candidates since outbreaks in 2015-2016 in Brazil linked the infection in some pregnant women to severe birth defects in their newborns. Zika is spread by the bite of infected mosquitos and through sex.
The proposed vaccine reported by scientists at the UH John A. Burns School of Medicine (JABSOM) in the journals Frontiers in Immunologyand mSphere, an open access journal of the American Society for Microbiology, is a recombinant subunit vaccine that uses only a small part (protein) of the Zika virus, produced in insect cells.
“We believe our vaccine candidate shows much promise particularly as it showed to require only two immunizations given three weeks apart and is a potentially safer alternative to other candidates already in clinical trials,” said Dr. Axel Lehrer, JABSOM (Assistant) Professor of Tropical Medicine and Infectious Disease.
Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
The research team at JABSOM included two senior graduate students who served as lead authors of the scientific research papers. Liana Medina, whose early training was directly supported by a National Institutes of Health Diversity in Health-Related Research grant, and Honolulu native Albert To are the graduate student lead authors.
Honolulu-based Hawai’i Biotech is a key partner in the vaccine development project with UH. Two of their scientists, Dr. Jaime Horton and David Clements, contributed to the most recent publication demonstrating vaccine efficacy in monkeys, along with collaborators from Bioqual Inc. of Rockville, Maryland, and the Department of Diagnostic Medicine/Pathobiology, Biosecurity Research Institute, College of Veterinary Medicine, at Kansas State University.
“The intense search for a Zika remedy since early 2016 has required us to be agile, and we believe our vaccine candidate research demonstrates that such quick-turnaround results can be achieved in academic and scientific partnerships here in Hawai’i,” said Dr. Lehrer. “It is incredibly gratifying that two of the scientists we are training to be the future of biomedical science played key roles in gathering, analyzing and reporting their conclusions. We hope Hawai’i’s citizens find that as inspiring as we do.”
Graduate student scientist and research co-author Liana Medina said there were chances to develop new skills at every step along the way. “Having the opportunity to see the vaccine’s development from its very first stages as Zika E protein being produced by Dr. Kenji Obadia, at the time also a student in our department, to a vaccine that is efficacious and safe in animal models was a unique learning experience. Being a part of the process allowed me grow as a student in this field,” said Medina.
Fellow graduate student and co-author Albert To said the team’s results “put us on the world-stage and highlight the talent we have here in Hawai?i.” He said, “Being involved with this project has given me a glimpse of the type of research and results needed to progress an idea to a potential preventative therapy used by thousands of people worldwide.”
The Latest on: Zika virus
via Google News
The Latest on: Zika virus
- How Can We Protect Ourselves from the Zika Virus this Holiday Season? on December 7, 2018 at 1:56 pm
In today’s world there are many things that one must watch out for and in California, one of those things has become the possible transmission of the Zika virus by mosquitoes who spread this disease. ... […]
- Risk Analysis releases special issue on communicating about Zika virus on December 7, 2018 at 8:54 am
Zika virus particles (red) shown in African green monkey kidney cells. Credit: NIAID Today, Risk Analysis, an International Journal, published a special issue, "Communicating About Zika," which ... […]
- Recombinant Subunit Vaccine Found Effective for Zika Virus on December 4, 2018 at 10:32 pm
A new vaccine candidate against Zika virus that it is effective in protecting both mice and monkeys from the infection was found by researchers at the University of Hawaii medical school. Demonstratin... […]
- New vaccine candidate for Zika virus proves to be effective in mice and monkeys on December 4, 2018 at 9:24 pm
Researchers at the University of Hawaii medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and monkeys from the inf... […]
- Inside Zika virus epicentre where worried medics fear deadly new epidemic on December 4, 2018 at 1:15 pm
It was a milestone little Juan Pedro Campos dos Santos’s family and friends feared they might never see. Born with debilitating microcephaly during the 2015 Zika virus outbreak, he reached his third b... […]
- New Zika vaccine effective in preclinical trials on December 4, 2018 at 12:46 pm
Zika virus particles (red) shown in African green monkey kidney cells. Credit: NIAID Researchers at the University of Hawaii medical school have successfully developed a vaccine candidate for the ... […]
- Zika virus can now be combated using 6 new antibodies on November 30, 2018 at 6:32 am
To help diagnose and treat mosquito-borne disease “Zika Virus”, a team of researchers led by Indian- origin doctor have developed 6 Zika virus antibodies. Ravi Durvasula from Loyola University in the ... […]
- Six antibodies with 'dual diagnostics' capability discovered to combat Zika virus on November 30, 2018 at 3:31 am
The antibodies "may have the dual utility as diagnostics capable of recognising Zika virus subtypes and may be further developed to treat Zika virus infection," said Ravi Durvasula from Loyola Univers... […]
- Antibodies to Diagnose and Fight Zika Virus on November 29, 2018 at 9:15 pm
Zika viral infection, a mosquito-borne disease which has infected more than 1.5 million people throughout the world, could be identified and treated easily using antibodies. The antibodies "may have t... […]
via Bing News